Epidemiology, geography and chronic kidney disease
AC McClellan, L Plantinga… - Current opinion in …, 2012 - journals.lww.com
Our understanding of the occurrence and outcomes of CKD will continue to be expanded
and deepened by the explicit study of attributes associated with place as a potential risk …
and deepened by the explicit study of attributes associated with place as a potential risk …
Prevalence of atrial fibrillation and antithrombotic therapy in hemodialysis patients: cross-sectional results of the Vienna InVestigation of AtriaL Fibrillation and …
O Koenigsbruegge, F Posch, M Antlanger, J Kovarik… - PLoS …, 2017 - journals.plos.org
Background Atrial fibrillation (AF) adds significant risk of stroke and thromboembolism in
patients on hemodialysis (HD). The aim of this study was to investigate the prevalence of AF …
patients on hemodialysis (HD). The aim of this study was to investigate the prevalence of AF …
A comparative study of carvedilol versus metoprolol initiation and 1-year mortality among individuals receiving maintenance hemodialysis
Background Carvedilol and metoprolol are the β-blockers most commonly prescribed to US
hemodialysis patients, accounting for∼ 80% of β-blocker prescriptions. Despite well …
hemodialysis patients, accounting for∼ 80% of β-blocker prescriptions. Despite well …
Atrial fibrillation and risk of stroke in dialysis patients
PURPOSE: Both stroke and chronic atrial fibrillation (AF) are common in dialysis patients,
but uncertainty exists in the incidence of new strokes and the risk conferred by chronic AF …
but uncertainty exists in the incidence of new strokes and the risk conferred by chronic AF …
The β-blocker to lower cardiovascular dialysis events (BLOCADE) feasibility study: a randomized controlled trial
MA Roberts, HL Pilmore, FL Ierino, SV Badve… - American Journal of …, 2016 - Elsevier
Background β-Blocking agents reduce cardiovascular mortality in patients with heart
disease, but their potential benefit in dialysis patients is unclear. We aimed to determine the …
disease, but their potential benefit in dialysis patients is unclear. We aimed to determine the …
Relationship between stroke and mortality in dialysis patients
Results The cohort consisted of 69,371 individuals representing> 112,000 person-years of
follow-up. Mean age±SD was 60.8±15.5 years. There were 21.1 (99% confidence interval …
follow-up. Mean age±SD was 60.8±15.5 years. There were 21.1 (99% confidence interval …
Patterns in blood pressure medication use in US incident dialysis patients over the first 6 months
Background Several observational studies have evaluated the effect of a single exposure
window with blood pressure (BP) medications on outcomes in incident dialysis patients, but …
window with blood pressure (BP) medications on outcomes in incident dialysis patients, but …
Effectiveness comparison of cardio-selective to non-selective β-blockers and their association with mortality and morbidity in end-stage renal disease: a retrospective …
Background Within-class comparative effectiveness studies of β-blockers have not been
performed in the chronic dialysis setting. With widespread cardiac disease in these patients …
performed in the chronic dialysis setting. With widespread cardiac disease in these patients …
Stroke and the “stroke belt” in dialysis: contribution of patient characteristics to ischemic stroke rate and its geographic variation
Geographic variation in stroke rates is well established in the general population, with
higher rates in the South than in other areas of the United States. ESRD is a potent risk …
higher rates in the South than in other areas of the United States. ESRD is a potent risk …
Variation in the level of eGFR at dialysis initiation across dialysis facilities and geographic regions
Results The proportion initiating dialysis with an eGFR≥ 10.5 ml/min per 1.73 m 2 was
35.3%, varying from 20.1% to 57.2% across geographic regions and from 10% to 67 …
35.3%, varying from 20.1% to 57.2% across geographic regions and from 10% to 67 …